Dosage and administration
Spray orally once or twice daily, at least 30 minutes before or after eating. Consult a physician for use in children under 12 years of age.
Spray orally once or twice daily, at least 30 minutes before or after eating. Consult a physician for use in children under 12 years of age.
Store in a cool, dry place.
Adrenocorticotrophin 6X, 12X, 30X, Gaba 6X, 12X, 30X, 3C, Glutamic Acid 6X, 12X, 30X, 3C, Norepinephrine 6X, 12X, 30X, 3C, 12C, 30C, Acetylcholine Chloride 6X, 12X, 30X, 3C, 12C, 30C, 1M, Adrenalinum 6X, 12X, 30X, 3C, 12C, 30C, 1M, L-Dopa 6X, 12X, 30X, 3C, 12C, 30C, 1M, Serotonin 6X, 12X, 30X, 3C, 12C, 30C, 1M, Thyroidinum (Suis) 6X, 12X, 30X 12C, Anacardium Orientale 6C, 30C, 200C, Baryta Carbonica 6C, 30C, 200C, Calcarea Carbonica 6C, 30C, 200C, Stramonium 30C, 1M.
For the temporary relief of loss of memory, metal weakness, senile dementia, forgetfulness, confusion, anxiety, brain fog, children with slow mental and physical development.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Spray orally once or twice daily, at least 30 minutes before or after eating. Consult a physician for use in children under 12 years of age.
Demineralized Water, 25% Ethanol
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
For the temporary relief of loss of memory, metal weakness, senile dementia, forgetfulness, confusion, anxiety, brain fog, children with slow mental and physical development.
MFD. FOR:
The Wellness Center for Research and Education, Inc.
1237 S. Victoria Ave. Suite 169
Oxnard, CA 93035
Theresa Dale's
NeuroBalance PRO
Homeopathic Neurotransmitter Formula
1 fl. oz (30 mL)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50181-0025-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3e6b-f424-e053-dadaa90a57ce | DRUG FACTS: |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .GAMMA.-AMINOBUTYRIC ACID | ACTIVE INGREDIENT | 2ACZ6IPC6I | 1 | |
| ACETYLCHOLINE CHLORIDE | ACTIVE INGREDIENT | AF73293C2R | 1 | |
| BARIUM CARBONATE | ACTIVE INGREDIENT | 6P669D8HQ8 | 1 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 1 | |
| DATURA STRAMONIUM | ACTIVE INGREDIENT | G6W4F0V8Z3 | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| GLUTAMIC ACID | ACTIVE INGREDIENT | 3KX376GY7L | 1 | |
| LEVODOPA | ACTIVE INGREDIENT | 46627O600J | 1 | |
| NOREPINEPHRINE | ACTIVE INGREDIENT | X4W3ENH1CV | 1 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 1 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE INGREDIENT | Y0F0BU8RDU | 1 | |
| SEROTONIN | ACTIVE INGREDIENT | 333DO1RDJY | 1 | |
| SUS SCROFA THYROID | ACTIVE INGREDIENT | 6RV024OAUQ | 1 | |
| .GAMMA.-AMINOBUTYRIC ACID | ACTIVE MOIETY | 2ACZ6IPC6I | 1 | |
| ACETYLCHOLINE | ACTIVE MOIETY | N9YNS0M02X | 1 | |
| BARIUM CATION | ACTIVE MOIETY | V645272HLN | 1 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 1 | |
| DATURA STRAMONIUM | ACTIVE MOIETY | G6W4F0V8Z3 | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| GLUTAMIC ACID | ACTIVE MOIETY | 3KX376GY7L | 1 | |
| LEVODOPA | ACTIVE MOIETY | 46627O600J | 1 | |
| NOREPINEPHRINE | ACTIVE MOIETY | X4W3ENH1CV | 1 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 1 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE MOIETY | Y0F0BU8RDU | 1 | |
| SEROTONIN | ACTIVE MOIETY | 333DO1RDJY | 1 | |
| SUS SCROFA THYROID | ACTIVE MOIETY | 6RV024OAUQ | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50181-0025 | 50181-0025-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CORTICOTROPIN | K0U68Q2TXA | ACTIB |
| .GAMMA.-AMINOBUTYRIC ACID | 2ACZ6IPC6I | ACTIB |
| GLUTAMIC ACID | 3KX376GY7L | ACTIB |
| NOREPINEPHRINE | X4W3ENH1CV | ACTIB |
| ACETYLCHOLINE CHLORIDE | AF73293C2R | ACTIB |
| EPINEPHRINE | YKH834O4BH | ACTIB |
| LEVODOPA | 46627O600J | ACTIB |
| SEROTONIN | 333DO1RDJY | ACTIB |
| SUS SCROFA THYROID | 6RV024OAUQ | ACTIB |
| SEMECARPUS ANACARDIUM JUICE | Y0F0BU8RDU | ACTIB |
| BARIUM CARBONATE | 6P669D8HQ8 | ACTIB |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | 2E32821G6I | ACTIB |
| DATURA STRAMONIUM | G6W4F0V8Z3 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 22473a08-4f13-40c7-a0db-a552ce232413 | b6637f00-3660-4fc5-acbd-4f1dfb02e80d | 2025-05-29 | Warnings | 22473a08-4f13-40c7-a0db-a552ce232413 b6637f00-3660-4fc5-acbd-4f1dfb02e80d |
Adverse event summaries are temporarily unavailable. Other product information remains available.